Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

IBB vs VYMI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to VYMI's +22.3%, and VYMI charges 0.07% to IBB's 0.44%.

askIQ about this page

askIQ about IBB and VYMI

Net assets: $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF, and $21.4bn on Sep 30, 2026 for Vanguard International High Dividend Yield ETF.

At a glance
+37.5%
IBB total return, 1 year
+22.3%
VYMI total return, 1 year
0.44%
IBB expense ratio
0.07%
VYMI expense ratio

Pair scorecard

VYMI costs 0.37 points a year less; their one-year returns differ by 15.2 points; VYMI is 1.9 times larger.

IBB vs VYMI: Differences, Returns & Fees
MeasureIBBVYMI
Return
Total return, 1 year+37.5%+22.3%
Drawdown
Below its high4.6%, high on Sep 3, 2026
Benchmark
What it tracksBiotechFTSE All-World ex US High Dividend Yield Index
Cost and size
Expense ratio0.44%0.07%
Net assets, as of Sep 30, 2026$11.2bn$21.4bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
Top ten holdings, share of the fund50%13.8%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, IBB and VYMI hold 0% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first IBB VYMI
EMERGENT BIOSOLUTIONS 0.02% 0.20%
CHINOOK THERAPEUTICS INC 0.00% 0.01%
Only in one fund ↓
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Only in VYMI
HSBC Holdings PLC 1.81%
Roche Holding AG 1.56%
Shell PLC 1.48%
Royal Bank of Canada 1.47%
Novartis AG 1.42%
Mitsubishi UFJ Financial Group Inc 1.35%
Nestle SA 1.25%
MediaTek Inc 1.21%
Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF VYMI Vanguard International High Dividend Yield ETF
Where it sits Thematic ETF Stock ETF
What it is Biotech Tracks an index of International High Dividend Yield
Total return, 1 year +37.5% +22.3%
Expense ratio 0.44% 0.07%
Already in the S&P 500 40.2% 0.0%
Holdings 245 1509
Net assets, IBB as of Oct 27, 2026 and VYMI as of Sep 30, 2026 $11.0bn $21.4bn

IBB and VYMI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

VYMI

VYMI tracks an index of International High Dividend Yield. Over the year to Oct 28, 2026 it returned +22.3% with distributions reinvested. The prospectus expense ratio is 0.07% a year. By its holdings published by its issuer as of Sep 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 1,509 positions, with the top ten at 13.8%. It sat 4.6% below its high of Sep 3, 2026 on Oct 28, 2026.

Questions people ask

Are IBB and VYMI in the same category?
IBB is a thematic ETF and VYMI is a stock ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or VYMI?
In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and VYMI +22.3%.
Which is cheaper, IBB or VYMI?
VYMI is cheaper, by 0.37 percentage points a year. That is about $37 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do IBB and VYMI overlap with the S&P 500?
By their latest filed holdings, 40% of IBB and 0% of VYMI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, IBB against VYMI, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-vymi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.